Cipher Pharmaceuticals (TSE:CPH – Free Report) (NASDAQ:CPHR) had its target price boosted by Citigroup from C$4.75 to C$8.00 in a report published on Wednesday, BayStreet.CA reports. They currently have a buy rating on the stock. Cipher Pharmaceuticals Stock Performance Shares of TSE CPH opened at C$7.70 on Wednesday. The business’s 50-day moving average price is […]